2023年至2028年女性用健康設備市場預測
市場調查報告書
商品編碼
1410052

2023年至2028年女性用健康設備市場預測

Women's Health Devices Market - Forecasts from 2023 to 2028

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 143 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

女性用健康設備市場預計將從2021年的253.1億美元成長到2028年的691.29億美元,複合年成長率為15.44%。

預計女性用健康設備市場將在整個預測期內穩定成長。女性用健康設備專用用於追蹤和治療與女性相關的疾病,例如乳癌。卵巢、卵巢癌和婦科健康等眾多健康問題和女性盛行率的上升是女性用健康設備市場的主要成長要素。此外,女性人口的增加和女性健康意識的增強預計將進一步推動女性用健康設備市場的發展。

多種疾病與女性有關

與女性相關的多種健康問題及其高盛行率是女性用的主要成長動力。女性比男性更容易感染愛滋病毒/愛滋病,影響 15 歲至 44 歲女性的健康問題中有三分之一是由性健康或生殖健康問題造成的。根據世界衛生組織報告,在非洲、中東和亞洲30個實行女性生殖器切割的國家中,到2023年,全球將有超過2億女孩和婦女遭受女性生殖器切割。此外,據世界衛生組織稱,2020年,幾乎每兩分鐘就有一名孕產婦死亡,每天有近800名婦女死於與懷孕和分娩有關的本可避免的原因。

乳癌和卵巢癌發生率增加

乳癌發生率的增加及其對健康的負面影響預計將增加女性用健康設備市場。 2020年,全球有685,000名女性死亡,230萬名女性被診斷出罹患乳癌。據世界衛生組織稱,過去五年已有 780 萬人被診斷出患有乳癌,到年終成為世界上最常見的癌症。其他女性特有的卵巢癌影響著廣大女性群體,並證明了女性用健康設備的需求。根據 WCRF 的數據,卵巢癌是第 18 位最常見癌症,也是女性第 8 位最常見癌症。

老年女性人口增加

全球女性人口不斷增加,對女性健康管理的需求不斷增加,從而激活了女性用健康設備市場。例如,根據政府於 2019 年至 2021 年進行的第五次全國家庭健康調查 (NFHS),印度目前首次實現每 1,000 名男性對應 1,020 名女性。此外,女性人口的老化正在推動女性用健康設備市場的發展,因為老化的女性人口更容易出現許多健康問題,例如糖尿病和卵巢癌。

市場機會

所有上述成長要素都為進入女性用健康設備市場提供了巨大的機會。此外,各種因素導致的女性健康投資需求的不斷增加,也正在擴大女性用健康器材市場。例如,2023 年1 月舉行的世界經濟論壇會議估計,投資約3 億美元用於針對女性的研究可帶來130 億美元的經濟回報,從而降低醫療成本。被認為具有節省資金、改善醫療保健的潛力。生活品質,並多年來提高世界勞動力的生產力。此外,女性主導的醫療保健公司正在經歷顯著成長,例如 Maven Clinic,該公司於 2021 年獲得了獨角獸地位。以投資為重點的會議加上政府措施和意識提升宣傳活動預計將對女性用健康設備市場產生積極影響。

預計北美將大幅成長

預計在預測期內,北美地區將佔據女性用健康設備市場的主要佔有率。造成這一比例的因素包括美國女性乳癌患者數量的增加以及女性健康意識的增加。據美國癌症協會稱,每年美國女性新發癌症病例中,乳癌佔 30%(三分之一)。此外,同一消息來源估計,到 2023 年,美國女性將發現 297,790 例新的侵襲性乳癌病例。此外,根據美國勞工統計局的數據,2020年女性勞動參與率約為56%,女性收入佔男性收入的百分比隨著時間的推移而增加,使女性用更健康。

市場主要發展

2023年1月,Mavano在CES 2023上展示了女性用健康智慧環Evie,並於2022年10月完成臨床試驗。該公司計劃尋求 FDA 批准首款消費者穿戴裝置(同時也是醫療設備)。 2022 年 10 月,Solera Health推出了全球首個數位點解決方案的女性健康網路。我們將建立一個涵蓋女性獨特健康需求生命週期的網路,從骨盆底功能障礙到更年期。 2021 年 6 月,Organon 成立,成為同等規模下唯一致力於女性健康的全球公司。 Organon 的使命是提供有效的藥物和解決方案,致力於幫助所有女性過上更健康的生活。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表

第2章調查方法

  • 調查資料
  • 調查過程

第3章執行摘要

  • 研究亮點

第4章市場動態

  • 市場促進因素
  • 市場抑制因素
  • 波特五力分析
  • 產業價值鏈分析

第5章女性用健康設備市場:依應用分類

  • 介紹
  • 癌症
  • 骨質疏鬆症
  • 感染疾病
  • 子宮肌瘤
  • 停經後綜合症
  • 懷孕
  • 女性節育手術
  • 其他

第6章女性用健康設備市場:依最終用戶分類

  • 介紹
  • 醫院
  • 婦產科門診
  • 診斷實驗室
  • 門診手術中心

第7章女性用健康設備市場:依地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 其他
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 印尼
    • 泰國
    • 其他

第8章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作

第9章 公司簡介

  • Abbott Laboratories
  • GE Healthcare
  • Caldera Medical
  • MedGyn Products
  • F. Hoffmann-La Roche
  • Hologic
  • Koninklijke Philips
  • Siemens AG
簡介目錄
Product Code: KSI061615715

The women's health devices market is expected to grow at a CAGR of 15.44% from US$25.310 billion in 2021 to US$69.129 billion in 2028.

The women's health devices market is anticipated to grow at a steady pace throughout the forecast period. Women's health devices are exclusively designed to track and treat women-related illnesses such as breast cancer. Numerous health issues in women such as breast cancer, ovarian cancer, and gynecologic health, and their growing prevalence rate is a major growth driver in the women's health devices market. Moreover, the rising female population coupled with increased awareness about women's health is further expected to boost the women's health devices market.

Numerous Associated Illnesses in Women

Multiple women-associated health concerns and their higher prevalence rate is a major growth drivers in the women's health devices market. Women are more susceptible to HIV/AIDS than men and one-third of the health problems affecting women between the ages of 15 and 44 have a sexual or reproductive health component. In the 30 countries in Africa, the Middle East, and Asia where female genital mutilation (FGM) is practiced, more than 200 million girls and women worldwide have suffered FGM in 2023 as per the WHO reports. Moreover, a maternal fatality happened nearly every two minutes in 2020, and nearly 800 women per day passed away from pregnancy- and childbirth-related avoidable causes according to the WHO.

Growing Prevalence of Breast and Ovarian Cancer

The growing incidence of breast cancer and its adverse health effects is contemplated to augment the women's health devices market. In 2020, 685,000 women worldwide died and 2.3 million women were diagnosed with breast cancer. Breast cancer was the most common cancer in the world by the end of 2020, with 7.8 million women living with breast cancer who had received a diagnosis within the previous five years as per the WHO. The other women-specific ovarian cancer cases are affecting a huge women population indicating the need for women's health devices. According to the WCRF, the 18th most prevalent cancer overall and the 8th most common cancer worldwide in women is ovarian cancer.

Increased Elderly Female Population

The female population is rising worldwide and it is increasing the requirement of women's health care thereby boosting the women's health devices market. For instance, India had 1,020 women for every 1,000 men for the first time, according to the government's fifth National Family and Health Survey (NFHS), which was conducted between 2019 and 2021. Moreover, the older female population is more prone to numerous health issues such as diabetes, and ovarian cancer thus rising aging female population is propelling the women's health devices market. For instance, there will be around 604 million elderly women in the world by 2025 according to the NCBI.

Multiple Awareness Programs on Women's Health

The awareness programs and initiatives being taken by several organizations worldwide are improving women's health awareness thereby aiding the women's health devices market. Additionally, the Office of Human Research and Community Engagement (OHRCE), Clinical Research Branch (CRB), and National Institute of Environmental Health Sciences (NIEHS) are leading the Women's Health Awareness (WHA) Community Engagement Programme, an innovative environmental health research, and advocacy initiative in North Carolina.

Opportunities in the Market

All the growth factors mentioned provide an immense opportunity to enter the women's health devices market. Moreover, the increasing investment need in women's health being addressed by various factors is also extending the women's health devices market. For instance, at a conference of the World Economic Forum in January 2023, it was recognized that an estimated $300 million investment in women's-specific research might result in a $13 billion economic return and save money on healthcare, improve quality of life, and add years to the global workforce's productivity. Further, women-led healthcare companies are growing significantly, for example, Maven Clinic received a unicorn status in 2021. The investment focussed conferences coupled with government efforts and awareness campaigns are expected to positively impact the women's health devices market.

North America is projected to grow significantly

The North American region is projected to hold a significant share of the women's health devices market during the forecast period. Various factors attributed to such a share are increasing cases of breast cancer in US women, and increased awareness about women's health. Each year, breast cancer accounts for 30% (or 1 in 3) of all new cases of US female cancer as per the American Cancer Society. Moreover, around 297,790 new instances of invasive breast cancer are estimated to be detected in US women in 2023 as per the same source. Moreover, women's participation in the workforce was around 56% in 2020 as per the US Labour Statistics Bureau, and women's earnings as a proportion of men's earnings have increased over time enabling women to spend more on their health and thereby boosting the women's health devices market.

Women Health Devices Market Players

  • A leading provider of pharmaceutical diagnostics, digital solutions, and medical technology worldwide is GE Healthcare. Voluson Women's Health Ultrasound offered by the company is available in a wider range including Voluson™ Expert Series to encompass the most progressive imagining capabilities, and Voluson™ Performance for OB, GYN, and assisted reproductive medicine.
  • Caldera Medical is a US-based manufacturer of medical devices with a singular focus on the health of women and a goal of raising women's standards of living. Products offered by the company are Desara® for stress urinary incontinence, Vertessa® for sacrocolpopexy procedures, and Benesta® System for hard-to-reach fundal and corneal tissue.
  • Hologic is one of the leading women's health companies focusing on breast health, gynecologic health, sexual health, body composition, and skeletal health. 3Dimensions®Mammography System and 3DQuorum™ Imaging Technology are offered by the company for breast health.

Key Market Developments

  • In January 2023, Mavano showcased the women's health smart ring Evie at CES 2023 and completed a clinical trial in October 2022. The company is planning to seek FDA clearance which will make it the first consumer wearable that is also a medical device.
  • In October 2022, Solera Health launched a first-of-its-kind Women's Health Network of digital point solutions. It is built to build a network that spans the lifecycle of women's unique health needs from pelvic floor dysfunction to menopause.
  • In June 2021, Organon launched as the only global company of its size focused on women's health. With a mission to provide effective medicines and solutions, Organon is focused on enabling every woman to live a healthier life every day.

Segmentation:

By Application

  • Cancer
  • Osteoporosis
  • Infectious Disease
  • Uterine Fibroids
  • Post-menopausal Syndrome
  • Pregnancy
  • Female Sterilization
  • Other

By End-Users

  • Hospitals
  • Obstetrics & Gynecology Clinics
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. WOMEN'S HEALTH DEVICES MARKET, BY APPLICATION

  • 5.1. Introduction
  • 5.2. Cancer
  • 5.3. Osteoporosis
  • 5.4. Infectious Disease
  • 5.5. Uterine Fibroids
  • 5.6. Post-menopausal Syndrome
  • 5.7. Pregnancy
  • 5.8. Female Sterilization
  • 5.9. Other

6. WOMEN'S HEALTH DEVICES MARKET, BY END USERS

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Obstetrics & Gynecology Clinics
  • 6.4. Diagnostic Laboratories
  • 6.5. Ambulatory Surgical Centers

7. WOMEN'S HEALTH DEVICES MARKET, BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. United Kingdom
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. The Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Israel
    • 7.5.4. Others
  • 7.6. Asia Pacific
    • 7.6.1. Japan
    • 7.6.2. China
    • 7.6.3. India
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations

9. COMPANY PROFILES

  • 9.1. Abbott Laboratories
  • 9.2. GE Healthcare
  • 9.3. Caldera Medical
  • 9.4. MedGyn Products
  • 9.5. F. Hoffmann-La Roche
  • 9.6. Hologic
  • 9.7. Koninklijke Philips
  • 9.8. Siemens AG